Clinical Trial Update: Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing accelerated versus standard BEP chemotherapy for intermediate- and poor-risk metastatic germ cell tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor

Drugs mentioned

• Bleomycin (bleomycin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: University of Sydney | Conditions: Germ Cell Tumor | Phase 3 | Status: RECRUITING